The long-acting GLP-1 receptor agonists segment dominated the market with the largest revenue share of 55.5% in 2024, driven by their superior efficacy in sustained weight loss, cardiovascular benefits, and the convenience of once-weekly dosing
And the 3 rd group a placebo
The detailed subgroup analysis of different GLP-1 RA groups compared to non-GLP-1 RA users is demonstrated in Table 4
In reality, the surge of interest in medications like Ozempic and Mounjaro has highlighted something Ive seen for years in my private nutritional therapy practice: for many, the struggle with binge eating and emotional eating is deeply physiological, yet has an element of imbalance in hunger and fullness signals
Oral semaglutide tablets work on your appetite regulation system by activating GLP-1 receptors in the brain, which can begin shifting your hunger signals within the first week
For detailed injection guidance applicable to all peptides, see our Peptide Injection Guide for Beginners